Palbociclib is a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6) used in the treatment of certain types of breast cancer.
571190-30-2
Ibrance;PD-0332991;Palbociclib
C24H29N7O2
Warning
Pharmaceutical
White to off-white powder
153-155
447.53